| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Revenue | $835.6M | -5.6% |
| Cost of Revenue | $573.9M | -2.2% |
| Gross Profit | $261.7M | -12.3% |
| R&D Expense | $19.2M | +10.3% |
| SG&A Expense | $148.9M | +11.9% |
| Operating Income | $79.9M | -41.8% |
| Pre-tax Income | $49.2M | -59.6% |
| Income Tax | $11.7M | -50.0% |
| Net Income | $37.5M |
| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.4M | -25.9% |
| Accounts Receivable | $114.8M | -8.2% |
| Inventory | $215.1M | +12.3% |
| Current Assets | $396.7M | +2.1% |
| Total Assets | $1.59B | +8.7% |
| Current Liabilities | $144.9M | -4.9% |
| Long-term Debt | $525.4M | +17.7% |
| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $83.9M | -23.7% |
| Capital Expenditures | $34.3M | +7.5% |
| Investing Cash Flow | -$153.9M | -69.5% |
| Financing Cash Flow | $57.9M | +939.1% |
| Free Cash Flow | $49.6M | -36.4% |
| -61.9% |
| EPS (Basic) | $1.14 | -62.4% |
| EPS (Diluted) | $1.14 | -62.3% |
| Total Liabilities |
| $735.8M |
| +10.0% |
| Stockholders' Equity | $854.6M | +7.5% |